Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM)
R. Alexander, S. Mavroukakis, S. Libutti, J. Pingpank, T. Beresneva, S. Marden, S. Steinberg, D. LiewehrVolume:
11
Language:
english
Pages:
1
DOI:
10.1007/bf02524154
Date:
February, 2004
File:
PDF, 154 KB
english, 2004